Wee Sunmee, Woolverton William L
Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, United States.
Pharmacol Biochem Behav. 2006 Jun;84(2):337-43. doi: 10.1016/j.pbb.2006.05.022. Epub 2006 Jul 10.
Previous research with psychostimulants has suggested a negative relationship between both potency and efficacy as a reinforcer and serotonergic potency, particularly relative to dopaminergic potency. The present experiment was designed to examine the relationship between the serotonergic activity and efficacy as a reinforcer by allowing rhesus monkeys (n=5) to self-administer amphetamine mixed with a serotonin releaser, fenfluramine. Additionally, the role of 5-HT2 receptors in the interaction between amphetamine and fenfluramine was investigated using ketanserin, a selective 5-HT2 receptor antagonist. Amphetamine and fenfluramine were combined in ratios of, respectively, 1:1 to 1:10 on a mg/kg basis and made available for self-administration under a progressive-ratio schedule of reinforcement. Amphetamine (0.0056-0.1 mg/kg/injection) functioned as a positive reinforcer with sigmoidal or biphasic dose-response functions. The addition of fenfluramine to amphetamine decreased the maximum responding, at least at the highest dose ratio (1:10, amphetamine/fenfluramine), in all monkeys. When measured after the pretreatment of ketanserin (1.0-3.0 mg/kg, i.m.), the self-administration of the mixture of amphetamine and fenfluramine at a ratio of 1:10 decreased in three monkeys and was unaffected in the fourth. These results support the notion of a negative influence of increased serotonergic neurotransmission on reinforcing efficacy of drugs that act via monoamine systems. However, the involvement of 5-HT2 receptors in the interaction between the serotonergic system and the reinforcing efficacy still remains equivocal.
先前对精神兴奋剂的研究表明,作为强化物的效力和功效与5-羟色胺能效力之间存在负相关关系,尤其是相对于多巴胺能效力而言。本实验旨在通过让恒河猴(n = 5)自行注射与5-羟色胺释放剂芬氟拉明混合的苯丙胺,来研究5-羟色胺能活性与作为强化物的功效之间的关系。此外,还使用5-羟色胺2受体选择性拮抗剂酮色林,研究了5-羟色胺2受体在苯丙胺与芬氟拉明相互作用中的作用。苯丙胺和芬氟拉明按毫克/千克计分别以1:1至1:10的比例混合,并在渐进比率强化程序下可供自行注射。苯丙胺(0.0056 - 0.1毫克/千克/注射)作为阳性强化物,具有S形或双相剂量反应函数。在所有猴子中,向苯丙胺中添加芬氟拉明至少在最高剂量比(1:10,苯丙胺/芬氟拉明)时降低了最大反应量。在酮色林(1.0 - 3.0毫克/千克,肌肉注射)预处理后进行测量时,1:10比例的苯丙胺和芬氟拉明混合物的自行注射量在三只猴子中减少,在第四只猴子中未受影响。这些结果支持了5-羟色胺能神经传递增加对通过单胺系统起作用的药物强化功效产生负面影响的观点。然而,5-羟色胺2受体在5-羟色胺能系统与强化功效相互作用中的参与情况仍不明确。